(Q41206248)

28 September 2017

1 reference

title

Glucocorticoid use in patients with preterm premature rupture of the fetal membranes (English)

1 reference

28 September 2017

2

Iams JD

1 reference

28 September 2017

Imseis HM

1

1 reference

28 September 2017

publication date

1 October 1996

1 reference

28 September 2017

published in

Seminars in Perinatology

1 reference

28 September 2017

volume

20

1 reference

28 September 2017

issue

5

1 reference

28 September 2017

page(s)

439-450

1 reference

Practice variation in the use of corticosteroids: A comparison of eight data sets

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Antenatal steroid therapy before 33 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Obstetrical attitudes to glucocorticoid treatment for fetal lung maturation: time for a change?

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

The use of corticosteroids for maturation of fetal lungs in patients with preterm prelabour rupture of the membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Accelerated appearance of osmiophilic bodies in fetal lungs following steroid injection

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Glucocorticoid and cAMP increase fatty acid synthetase mRNA in human fetal lung explants

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Scientific basis and therapeutic regimens for use of antenatal glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Comparative teratogenicity of triamcinolone acetonide, triamcinolone, and cortisol in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Teratogenic potential of corticosteroids in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Effects of Low-Dose Prenatal Corticosteroid Administration on the Premature Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Glucocorticoid prophylaxis for respiratory distress syndrome: A review of potential toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Maternal betamethasone and fetal growth and development in the monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Effects of antenatal dexamethasone administration in the infant: Long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Effects of antenatal steroid therapy on mortality and morbidity in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Effects of corticosteroids on the biochemical maturation of rat brain: postnatal cell formation

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Reductions in size and total DNA of cerebrum and cerebellum in adult mice after corticosterone treatment in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Effects of perinatal thyroxine and/or corticosterone treatment on the ontogenesis of hypothalamic and mesencephalic norepinephrine and dopamine content.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Maternal corticosteroid therapy and the fetal brain in experimental hyaline membrane disease

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

The effects of hydrocortisone on the development of the amine systems in the fetal brain

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Increased voluntary running and decreased motor coordination in mice after neonatal corticosterone implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Effects of corticosteroids on sexual differentiation of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Antenatal betamethasone therapy: effects on maternal, fetal, and neonatal mineralocorticoids, glucocorticoids, and progestins

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Some physiological, biochemical, and behavioral consequences of neonatal hormone administration: Cortisol and thyroxine

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Maternal corticosteroid and tocolytic treatment and morbidity and mortality in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

The effect of corticosteroid therapy in the very premature infant. March of Dimes Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Evidence from multicenter neworks on the current use and effectiveness of antenatal corticosteroids in low birth weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Injection of corticosteroids into mother to prevent neonatal respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Results of a double-blind controlled study on the use of betamethasone in the prevention of respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

The influence of betamethasone and orciprenaline on the incidence of respiratory distress syndrome in the newborn after preterm labour

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Maternal glucocorticoid in unplanned premature labor. Controlled study on the effects of betamethasone phosphate on the phospholipids of the gastric aspirate and on the adrenal cortical function of the newborn infant

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation versus use of steroids and timed delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

The effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome in preterm gestations with premature rupture of membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Treatments of preterm premature rupture of the membranes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Antenatal corticosteroid therapy: A meta-analysis of the randomized trials, 1972 to 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Obsevational evidence for the efficacy of antenatal steroids from randomized studies of surfactant replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Antenatal corticosteroid treatment and neonatal outcomes for infants 501 to 1500 gm in the Vermont-Oxford trials network

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: The NICHD neonatal research network

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Prevention of necrotizing enterocolitis in the rat with prenatal cortisone

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Effect of corticosteroid use before preterm delivery: outcome of periventricular hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

The relationship between premature rupture of the membranes and the respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

The relationship between premature rupture of the membranes and the respiratory distress syndrome. An update and plan of management

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Association between ruptured membranes, tocolytic therapy, and respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Prolonged rupture of fetal membranes and decreased frequency of respiratory distress syndrome and patent ductus arteriosus in preterm infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Conservative management of premature rupture of the membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Premature labor and premature rupture of the membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

The neonatal significance of selected perinatal events among infants of low birth weight. II. The influence of ruptured membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Failure of Association of Premature Rupture of Membranes with Respiratory-Distress Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Reduction of incidence and mortality of respiratory distress syndrome by adminstration of hydrocortisone to mother

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Conservative management of preterm premature rupture of the fetal membranes in a low socioeconomic population

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Accelerated pulmonary maturation from preterm premature rupture of membranes: a myth

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

Selection of study patients with premature rupture of membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2896%2980011-5

7 January 2021

10.1016/S0146-0005(96)80011-5

Identifiers

DOI

1 reference

28 September 2017

1 reference